Back to Nuveen, LLC Nuveen, LLC

TGTXTGTX
6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in TG THERAPEUTICS INC

Yes. Nuveen Investments holds 1,625,876 shares of TGTX (TG Therapeutics), worth $89.3M, as of its Q2 2026 13F filing. It increased the position by 178,798 shares (+12.4%) from Q1 2026. Nuveen Investments has held TGTX in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$89.3M

Current Shares

1.6M

Total Value Change

+$59.9M

Total Shares Change

+879,180

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+12.4%
$89.3M0.0%$54.94
34
2026-Q1
Increased
1.4M
+51.8%
$48.1M0.0%$33.22
41
2025-Q4
Increased
953,206
+34.1%
$28.4M0.0%$29.81
37
2025-Q3
Increased
710,772
+8.2%
$25.7M0.0%$36.13
31
2025-Q2
Decreased
657,153
-12.0%
$23.7M0.0%$35.99
0
2025-Q1
First report
746,696
-
$29.4M0.0%$39.43
0

Other major holders of TGTX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used